This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.
Total anomalous pulmonary venous connection (TAPVC)
1. History
Total anomalous pulmonary venous connection (TAPVC) is a congenital heart malformation in which all the pulmonary veins connect to systemic veins or the right atrium rather than the left atrium. It was first described by Wilson in 1798 in an autopsy report, and until the early 20th century it was known only from autopsy findings.
Clinical surgical treatment began in earnest after Lewis and colleagues achieved the first successful surgical repair using hypothermia in 1956. In 1962, Cooley and Ochsner reported repair using cardiopulmonary bypass. Surgical approaches were refined through the 1970s~1980s, and as the occurrence of pulmonary vein obstruction (pulmonary vein stenosis, PVS) came to be recognized as a major complication, surgical techniques were improved.
Among the surgical innovations to reduce pulmonary vein stenosis complications, the most important was the introduction of the sutureless technique (pericardium-in-situ repair), and since the 2000s excellent results have been reported in cases with severe pulmonary vein stenosis or recurrent stenosis. In Korea as well, the sutureless technique has been actively applied at major centers since the 2010s.
2. Causes
The cause of TAPVC arises from the process of pulmonary vein development in the embryonic period.
In normal development, around 4~5 weeks of gestation the primitive common pulmonary vein arises from the posterior wall of the left atrium and connects with the splanchnic plexus of the lungs. The left atrium then absorbs the common pulmonary vein, so that the individual pulmonary veins connect directly to the left atrium.
TAPVC is known to occur when this absorption process fails or when the primitive pulmonary vein maintains its connection with systemic veins (supracardiac type: SVC, left superior vena cava, right-sided veins; cardiac type: coronary sinus, right atrium; infracardiac type: portal vein, hepatic veins, IVC; mixed type) instead of the left atrium.
The Darling classification (1957) remains the standard classification in use today:
Type I (Supracardiac): about 45~55%. The pulmonary veins connect to the left innominate vein or superior vena cava through a vertical vein.
Type II (Cardiac): about 15~25%. The pulmonary veins connect directly to the coronary sinus or right atrium.
Type III (Infracardiac): about 20~30%. The pulmonary veins descend below the diaphragm and connect to the portal vein, hepatic veins, or inferior vena cava. Pulmonary vein obstruction is most common and severe.
Type IV (Mixed): about 5~10%. Two or more types of connection coexist.
3. Genetics
The genetics of TAPVC differs according to the presence of associated malformations.
Heterotaxy-related:
TAPVC accompanies right isomerism (asplenia syndrome) at a particularly high frequency (~40~50%).
CITED2, NKX2.5, and GATA4 variants have also been reported as part of complex congenital heart malformations.
Isolated sporadic TAPVC:
Cases with an identified specific genetic cause are few, and most are considered multifactorial.
Associated genes are being explored in some reports of familial TAPVC, but none has been established yet.
Turner syndrome (45,X):
Pulmonary vein abnormalities are rarely reported.
When TAPVC is diagnosed, whether heterotaxy syndrome is suspected is assessed, and when complex malformations accompany it, chromosomal microarray and a cardiovascular genetic panel test are considered.
4. General epidemiology
TAPVC shows a moderate frequency among congenital heart malformations.
Incidence: about 6~12 per 100,000 births. Accounts for about 1~3% of all congenital heart malformations.
Sex: there is a tendency toward a slightly higher frequency in boys, but a statistically significant difference is not consistently found.
Isolated TAPVC: about 70~80% of all TAPVC.
TAPVC with heterotaxy syndrome: about 20~30% of the total.
Pulmonary vein obstruction (obstructed TAPVC) differs by type:
Infracardiac type: obstruction accompanies in ~80% or more → neonatal emergency surgery required
Supracardiac type: obstruction accompanies in ~20~30%
Cardiac type: obstruction is rare
In Korea it is eligible for special copayment reduction V150, and several hundred cases are diagnosed each year. Treatment is provided at specialized pediatric cardiac surgery centers.
5. Pathophysiology
The key point of the pathophysiology of TAPVC is that, because all the pulmonary veins connect to systemic veins or the right atrium, the pulmonary and systemic circulations must be connected at the atrial level (atrial septal defect or patent foramen ovale) in order to survive.
Basic hemodynamics:
Pulmonary venous blood (oxygenated blood) → systemic venous system or right atrium → part of it shunts to the left atrium through the atrial septal defect in the right atrium → left ventricle → systemic circulation.
The left atrium and left ventricle depend only on the shunt flow and so are underfilled.
Both the systemic and pulmonary circulations are filled with blood in which oxygenated and unoxygenated blood are mixed (complete mixing circulation).
Obstructed TAPVC:
When there is stenosis in the pulmonary venous return pathway, pulmonary venous hypertension → pulmonary edema → severe hypoxemia occur.
In the infracardiac type, severe obstruction occurs when the connecting vessel passing through the diaphragm (descending vertical vein) is narrow or portal venous pressure is high.
Obstructed TAPVC is a neonatal medical emergency, and survival is impossible without immediate surgical repair.
Unobstructed TAPVC:
Pulmonary blood flow is abundant (excessive pulmonary blood flow) and heart failure develops gradually.
Right ventricular volume overload gradually causes cardiomegaly and right heart failure.
6. Symptoms
The symptoms of TAPVC differ greatly depending on the presence of obstruction and the type.
Recurrent respiratory infections: increased susceptibility due to pulmonary overcirculation.
Cardiomegaly and right heart failure: hepatomegaly, lower limb edema (in severe cases).
Even in unobstructed TAPVC, if left untreated, pulmonary vascular obstructive disease progresses and the opportunity for surgery may be lost.
7. Signs
Physical examination findings in patients with TAPVC:
Common findings:
Cyanosis: generalized cyanosis. Very severe in obstructed TAPVC, mild to moderate in unobstructed.
Single or widely fixed split second heart sound: reflects right ventricular overload.
Hepatomegaly: reflects volume overload and heart failure.
Heart murmurs by type:
Systolic ejection murmur at the left upper sternal border: increased right ventricular outflow tract flow.
Diastolic murmur (rumble) at the apex to left lower sternal border: increased tricuspid valve flow.
In the cardiac type of TAPVC with connection through the coronary sinus, there may be no specific murmur.
Characteristic chest X-ray findings:
Supracardiac type: 'figure 8' or 'snowman' heart shape. The vertical vein and dilated superior vena cava merge, making the upper mediastinum look wide.
Infracardiac type (obstructed): pulmonary venous congestion and pulmonary edema are prominent without cardiomegaly. 'White-out lung' pattern.
ECG: right ventricular hypertrophy (right axis deviation, right ventricular hypertrophy pattern in V1), P wave abnormalities.
Echocardiography: the common venous chamber behind the left atrium, right heart dilation, left heart findings, and the direction of flow across the atrial septal defect are confirmed.
8. Screening
Screening tests for early detection of TAPVC:
Prenatal ultrasound:
When abnormal four-chamber view findings (a common venous chamber behind the left atrium, abnormal pulmonary vein connection) are found on detailed ultrasound at 18~22 weeks of gestation, fetal echocardiography is performed.
Prenatal diagnosis is decisively important especially in obstructed TAPVC, because it allows delivery planning and preparation for immediate surgery right after birth.
However, TAPVC, especially abnormal pulmonary vein connection, is one of the malformations difficult to diagnose on prenatal ultrasound (sensitivity ~40~60%).
Neonatal pulse oximetry:
SpO₂ screening within 24~48 hours after birth. If SpO₂ <95% or the difference between upper and lower limbs >3%, echocardiography is performed immediately.
In obstructed TAPVC, SpO₂ is very low and it is easily detected on screening.
In unobstructed TAPVC, the initial SpO₂ may be relatively high and the infant may pass screening, so clinical suspicion is important.
Suspected association with heterotaxy syndrome:
When complex malformations or abnormal visceral position are suspected, abdominal ultrasound is performed together with echocardiography to confirm visceral position and presence of the spleen.
9. Diagnosis
Tests used for diagnosis and preoperative evaluation of TAPVC:
Echocardiography:
First-line diagnostic tool. Assesses the location and connecting pathway of the common venous chamber, presence of obstruction, size and flow direction of the atrial septal defect, right heart size, and left heart size (whether underfilled).
There are cases in which the anatomy of the pulmonary vein connection is difficult to clarify, and it is supplemented with CT or MRA.
The degree of obstruction is evaluated by measuring the flow velocity of each pulmonary vein with Doppler (normal peak velocity <1.5 m/s; ≥2 m/s with obstruction).
Cardiovascular CT angiography (CTA):
Evaluates in three dimensions the connecting pathway of the pulmonary veins, size of the common venous chamber, site of stenosis, and relation to surrounding structures.
Essential for confirming anatomy before surgery, and especially important in mixed-type TAPVC.
Cardiac MRI/MRA:
Can evaluate pulmonary vein anatomy and blood flow without radiation exposure, which is useful for postoperative follow-up.
Cardiac catheterization:
When there is a restrictive atrial septal defect (restrictive ASD) and pulmonary congestion is severe, immediate balloon atrial septostomy (Rashkind procedure) is performed. This is an emergency palliative measure that helps stabilize the patient before surgery.
10. Treatment
Treatment of TAPVC is complete surgical repair, and the timing is decided by the presence of obstruction.
Obstructed TAPVC: neonatal emergency surgery
Surgical repair is performed immediately after diagnosis or as soon as possible. Medical treatment (PGE1, oxygen, diuretics) is used only for temporary stabilization.
In obstructed TAPVC, PGE1 does not help, and high-concentration oxygen may also lower pulmonary vascular resistance and worsen pulmonary congestion.
Surgical methods:
Standard repair: under cardiopulmonary bypass, the common pulmonary venous confluence is anastomosed directly to the posterior wall of the left atrium, and the systemic venous connection (vertical vein, coronary sinus connection, etc.) is ligated. The atrial septal defect is closed with a patch or sutures.
Sutureless repair (technique without suture lines): an anastomosis using pericardium in situ between the common pulmonary venous confluence and the posterior wall of the left atrium, which is effective in lowering the incidence of pulmonary vein stenosis. It is applied preferentially when pulmonary vein stenosis is severe or restenosis has occurred.
Unobstructed TAPVC: elective surgery is performed as early as possible (within several weeks after diagnosis). Correction before pulmonary vascular disease progresses is important.
TAPVC with heterotaxy syndrome: the surgical plan varies with the complexity of the associated malformations, and single-ventricle palliation is often required.
11. Prognosis
The surgical prognosis of TAPVC has continued to improve.
Operative mortality:
Isolated TAPVC (without obstruction): <5% at specialized centers
Obstructed TAPVC: 5~15% (neonatal emergency surgery, severe pulmonary edema)
With heterotaxy syndrome or mixed type: 15~30% or more
Long-term survival:
When isolated repair is successful: 10-year survival about 80~90%, 20-year survival about 75~85%
Major long-term complication: pulmonary vein stenosis (PVS)
The most serious complication, occurring in about 10~20% after surgery.
Divided into residual stenosis occurring immediately after surgery and progressive PVS that advances after several weeks to months.
Progressive PVS (diffuse/progressive type): progressive stenosis due to intimal proliferation and neointima formation. Prognosis is very poor.
The sutureless technique can reduce the incidence of PVS but cannot completely prevent it.
PVS treatment: repeat surgery (re-anastomosis), balloon dilation, stent placement. Lung transplantation is considered in severe cases.
Other complications: arrhythmia (atrial fibrillation, atrial flutter), recurrence of atrial septal defect, right heart dysfunction.
12. Prevention
There is no established method of preventing the occurrence of TAPVC. Strategies to improve prognosis are as follows.
Enhanced prenatal diagnosis:
On detailed ultrasound at 18~22 weeks of gestation, the pulmonary vein connection is actively evaluated, not just the four-chamber view.
When diagnosed prenatally, a multidisciplinary team is prepared before delivery and delivery is planned at a tertiary hospital where immediate surgery is possible.
When obstructed TAPVC is diagnosed prenatally, delivery at a hospital prepared for emergency surgery immediately after birth increases survival.
Prevention and early detection of pulmonary vein stenosis:
The sutureless surgical technique is actively applied to minimize tension at the anastomosis.
Pulmonary vein flow velocity is monitored by regular (every 3~6 months) postoperative echocardiography to detect stenosis early.
If pulmonary vein flow velocity increases or clinical symptoms (dyspnea, exercise intolerance, cyanosis) recur, CT/MRA and cardiac catheterization are performed immediately.
Genetic counseling:
When heterotaxy syndrome accompanies, the underlying genetic cause is investigated and family counseling is provided.
The recurrence risk of isolated TAPVC is low (about 1~3%), but fetal echocardiography is recommended in subsequent pregnancies.
Prevention of respiratory infection: because respiratory infection before and after surgery can cause clinical deterioration, infection prevention measures are taken, including RSV prophylaxis (high-risk infants during the RSV season).
13. References
Darling RC, et al. Total pulmonary venous drainage into the right side of the heart: report of 17 autopsied cases not associated with other major cardiovascular anomalies. Lab Invest. 1957;6(1):44-64. PMID:13413123
Lupinetti FM, et al. Total anomalous pulmonary venous connection: repair by sutureless technique. Ann Thorac Surg. 1993;55(5):1219-1223. PMID:8488439
Hancock Friesen CL, et al. Total anomalous pulmonary venous connection: an analysis of current management strategies in a single institution. Ann Thorac Surg. 2005;79(2):596-606. PMID:15680839
Photiadis J, et al. Sutureless repair of total anomalous pulmonary venous connection. Eur J Cardiothorac Surg. 2008;34(4):883-887. PMID:18640050
Bando K, et al. Surgical management of total anomalous pulmonary venous connection: 30 years of experience. Circulation. 1996;94(9 Suppl):II12-16. PMID:8901722
Michielon G, et al. Total anomalous pulmonary venous connection: long-term appraisal with evolving technical solutions. Eur J Cardiothorac Surg. 2002;22(2):184-191. PMID:12142185
Jenkins KJ, et al. Threshold for reporting congenital cardiac defects in infancy: the Baltimore-Washington Infant Study. Am J Epidemiol. 1995;141(9):789-797. PMID:7741122
Seale AN, et al. Total anomalous pulmonary venous connection: outcome of postoperative pulmonary venous obstruction. J Thorac Cardiovasc Surg. 2013;145(4):1083-1090. PMID:22677155
Karamlou T, et al. Outcomes after late reoperation in patients with repaired total anomalous pulmonary venous connection. Ann Thorac Surg. 2007;84(3):873-878. PMID:17720393
Yanagawa B, et al. Sutureless repair for pulmonary vein stenosis-midterm results. J Thorac Cardiovasc Surg. 2014;147(1):279-287. PMID:23962567